home / National Stock Exchange of India (NSE) Q4FY25 Highlights
All figures in INR Crs unless otherwise stated
NSE Trades at a CMP of ₹1,540/- per share at a P/E multiple of 31.28 based on the EPS of ₹49.24
While BSE trades at a CMP of ₹6,245/- per share at a P/E multiple of 64.94 based on the EPS of ₹96.17
📊Total Income
Q4FY24- ₹5,080.04
Q3FY25 – ₹4,806.55
Q4FY25 – ₹4,396.75
FY24 – ₹16,433 (Other Income ₹1,653)
FY25 – ₹19,177 (other Income ₹2,036)
📊Total Expenses
Q4FY24 – ₹1,130.74
Q3FY25 – ₹1,015.18
Q4FY25 – ₹1,118.84
FY24 – ₹3,608
FY25 – ₹4,806
📊Net Profit
Q4FY24 – ₹2,487.24
Q3FY25 – ₹3,833.58
Q4FY25 – ₹2,650.11
FY24 – ₹8,305
FY25 – ₹12,187
📊EPS
Q4FY24 – ₹10.05
Q3FY25 – ₹15.49
Q4FY25 – ₹ 10.71
FY24 – ₹33.56
FY25 – ₹49.24
📊Net Worth
FY24 – ₹23,974
FY25 – ₹30,353
📑 KEY HIGHLIGHTS – Q4FY25
➡️Revenue from Operations decreased this quarter by ₹578Cr.
The segment reporting of operating revenue for Q4FY25 was as follows:-
1) Trading Services: ₹3,426 (3,975 in Q3)
2) Clearing Services: ₹420 (640 in Q3)
3) Other Segments: ₹145 (153 in Q3)
The decrease in revenue was primarily due to decrease in Trading and Clearing services
➡️The Total standalone revenue has increased by ₹1,571 cr to ₹5,860cr in Q4FY25 from ₹4,289 cr in Q3FY25
This increases primarily due to an increase in other income because of the the subsidiary dividends received by the company
➡️The Standalone PAT has increased by ₹1,749 cr to ₹4,040 cr In Q4FY25 from ₹2,291 cr in Q3FY25
➡️The increase in Total Expenses in Q4FY25 was of ₹103 Cr on a q-o-q basis. This increase was primarily due to decrease in Other expenses
➡️The core SGF stood at ₹12,082 cr as on March 2025
➡️ The company’s market share in the Equity Options stood at 87.4% as of FY25
➡️Operating Profit margin as on Q4FY25 is 70% as compared to 63% in Q4FY24
➡️NSE has declared a dividend of ₹35 per equity share. This includes a special one time dividend of ₹11.46.
The dividend record date is yet to be declared.
For more quarterly result updates and other news, go on to www.chryseum.in
Thanks & Regards
Chryseum Advisors LLP
India’s First Private Market Benchmark. Providing institutional clarity to the unlisted securities market.
| Cookie | Duration | Description |
|---|---|---|
| cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
| cookielawinfo-checkbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
| cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
| cookielawinfo-checkbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
| cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
| viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |